Effect of Cryopreserved Placental Mesenchymal Stromal Cells on Pro-Inflammatory State In Experimental Type 2 Diabetes mellitus
DOI:
https://doi.org/10.15407/cryo25.04.371Keywords:
cryopreserved placental mesenchymal stromal cells, streptozotocin-induced diabetes, diabetic retinopathy, C-reactive protein, tumor necrosis factor a, pro-inflammatory cytokinesAbstract
Diabetic retinopathy is the most common microvascular complications of Diabetes mellitus and one of the leading causes of a vision loss among people of working age. In this regard, the study of pathogenesis and development of new effective methods to prevent and treat diabetic retinopathy is one of the urgent tasks of current ophthalmology. Of particular interest is the use of mesenchymal stromal cells capable of penetrating into the injury site of blood vessels and tissue ischemia as well as having an anti-inflammatory effect. The paper assessed a therapeutic efficiency of cryopreserved placental mesenchymal stromal cells (cPMSCs) in experimental diabetes induced by streptozotocin and high-calorie diet. The results demonstrated that the cPMSCs preparation had an anti-inflammatory effect manifested in reducing the concentration of C-reactive protein and tumor necrosis factor-a in the blood serum, likely contributing to the prevention of diabetic microvascular complications.
Probl Cryobiol Cryomed 2015; 25(4):371-378.
References
Abdulrazzak H., Moschidou D., Jones G. et al. Biological cha-racteristics of stem cells from foetal, cord blood and extra-embryonic tissues. J R Soc Interface 2010; 7(Suppl. 6): S689–S706. CrossRef PubMed
Cacicedo J.M. Benjachareowong S., Chou E. et al. Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes 2005; 54(6): 1838–1845. CrossRef PubMed
Doganay S., Evereklioglu C., Er H. Comparison of serum NO, TNF-a, IL-1, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye 2002; 16(2): 163–170. CrossRef PubMed
Glantz S.A. Primer of biostatistics. Moscow: Praktika; 1998.
Joussen A.M., Poulaki V., Mitsiades N. et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. The FASEB Journal 2002; 16(3): 438–440. PubMed
Hernandez C., Segura R.M., Fonollosa A. et al. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy. Diabetic Medicine 2005; 22(6): 719–722. CrossRef PubMed
Kastelan S., Tomic M., Gverovic Antunica A et al. Inflammation and pharmacological treatment in diabetic retinopathy. Mediators of Inflammation 2013: 2013:213130.
Klein B.E.K., Knudtson M.D., Tsai M.Y., Klein R. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol 2009; 127(9): 1175–1182. CrossRef PubMed
Kozar V.V., Kudrya M.Ya. Determination method of C-reactive protein concentration by express method. Patent 38911 (Ukraine), IPC G01N 33/544.
Lin S., Yang J., Wu G. et al. Preventive effect of taurine on experimental type II diabetic nephropathy. J Biomed Sci 2010; 17(Suppl. 1): 46–56. CrossRef PubMed
Lobyntseva G.S. Preservation method of human hematopoietic cells. Patent 46673 A (Ukraine), IPC A01N 1/02.
Mohammad G., Siddiquei M.M., Abu El-Asrar A.M. Poly (ADP-ribose) polymerase mediates diabetes-induced retinal neuro-pathy. Mediators of Inflammation 2013; 2013:510451. CrossRef PubMed
Spijkerman A.M., Gall M.A., Tarnow L. et al. Endothelial dys-function and low-grade inflammation and the progression of retinopathy in type 2 diabetes. Diabetic Medicine 2007; 24(9): 969–976. CrossRef PubMed
Stitt A.W., Lois N., Medina R.J. et al. Advances in our under-standing of diabetic retinopathy. Clinical Science 2013; 125(1): 1–17. CrossRef PubMed
Tomic M., Ljubic S., Kastelan S. The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy. Collegium Antropologicum 2013; 37(Suppl. 1): 51–57. PubMed
Tsagias N., Koliakos I., Lappa M. et al. Placenta perfusion has hematopoietic and mesenchymal progenitor stem cell potential. Transfusion 2011; 51(5): 976–985. CrossRef PubMed
van Hecke M.V., Dekker J.M., Nijpels G. et al. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn study. Diabetologia 2005; 48(7): 1300–1306. CrossRef PubMed
Vincent H.K., Innes K.E., Vincent K.R. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes Metab 2007; 9(6): 813–839. CrossRef PubMed
Volarevic V., Arsenijevic N., Lukic M.L., Stojkovic M. Concise review: mesenchymal stem cell treatment of the complications of Diabetes mellitus. Stem Cells 2011; 29: 5–10. CrossRef PubMed
Downloads
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Yuriy A. Demin, Mariya Yu. Demina, Vladimir A. Shabliy, Andrey N. Sergienko
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).